Microneedling is a well-established, broadly tolerated procedure with a strong safety profile across skin types when performed with sterile, single-use needle cartridges by a trained clinician.

Common reactions Redness, warmth, mild swelling, and skin sensitivity immediately following treatment — typically resembling a moderate sunburn. Most reactions resolve within 24–48 hours. Mild pinpoint bleeding during the procedure is normal at deeper depth settings.

Rare side effects Prolonged redness, post-inflammatory hyperpigmentation, infection, or milia formation — uncommon when sterile protocol is maintained and post-care instructions are followed. Risk increases with active skin conditions or compromised barrier function at time of treatment.

Contraindications Active acne breakouts, open wounds, or active skin infection in the treatment area; recent isotretinoin use (within 6–12 months); blood thinning medications or clotting disorders; history of keloid scarring; pregnancy; or certain autoimmune skin conditions such as psoriasis or eczema in the treatment zone. PDRN enhancement is contraindicated in patients with known fish allergies.

Disclosure required Inform your provider of all medications and supplements — particularly retinoids, anticoagulants, and photosensitizing drugs — recent procedures, history of cold sores near the treatment area, active skin conditions, known fish allergy if considering PDRN, and any previous reactions to skin treatments.

Results develop progressively over 4–8 weeks following each session as collagen remodeling matures. A series approach produces the most significant cumulative improvement. Individual results vary based on skin type, concern severity, treatment frequency, and post-care adherence.